Catheter Precision, Inc. Common Stock Q2 EPS $(5.57) Down From $(2.94) YoY, Sales $93.00K Down From $96.00K YoY
Portfolio Pulse from Benzinga Newsdesk
Catheter Precision, Inc. (AMEX: VTAK) reported a significant increase in quarterly losses, with EPS at $(5.57), down 89.46% from $(2.94) YoY. Sales also decreased by 3.13% to $93.00K from $96.00K YoY.
August 14, 2024 | 12:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Catheter Precision, Inc. reported a significant increase in quarterly losses and a slight decrease in sales. EPS dropped to $(5.57) from $(2.94) YoY, and sales fell to $93.00K from $96.00K YoY.
The significant increase in quarterly losses and the slight decrease in sales are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100